Drake & Associates’s Amgen AMGN Stock Holding History

Drake & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,455	Closed	-$469K	–	90
2024 Q3	$469K	Buy	+1,455	New	+$476K	0.15%	54

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Drake & Associates's AMGN Position: Q4 2024 in Review

Drake & Associates sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,455 shares — an estimated $469K sold.

Drake & Associates first reported a position in AMGN in Q3 2024 and held it in 1 quarter. The position peaked at $469K in Q3 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

Drake & Associates reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
Drake & Associates sold 1,455 Amgen shares in Q4 2024, an estimated $469K.
Drake & Associates first reported a position in Amgen in Q3 2024 and held it in 1 quarter.
Drake & Associates's Amgen position peaked at $469K in Q3 2024.
2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Drake & Associates's 13F filing for Q4 2024, filed 10 Feb 2025.